Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Fowler's Syndrome
NCT02428881Phase 3Completed
- Sponsor
- University College London
- Start
- Nov 2009
- Primary completion
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of botulinum toxin type A in acute urinary retention, sponsored by University College London. Started Nov 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
acute urinary retention
Beyond the preview
Go deeper on NCT02428881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02428881.